BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30328647)

  • 21. The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome.
    Ciccia F; Guggino G; Giardina A; Ferrante A; Carrubbi F; Giacomelli R; Triolo G
    Expert Rev Clin Immunol; 2014 Apr; 10(4):533-41. PubMed ID: 24490899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
    Alunno A; Bistoni O; Bartoloni Bocci E; Caterbi S; Bigerna B; Pucciarini A; Tabarrini A; Mannucci R; Beghelli D; Falini B; Gerli R
    Reumatismo; 2013 Oct; 65(4):192-8. PubMed ID: 24192564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
    Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic Nervous System Dysfunction in Primary Sjögren's Syndrome.
    Davies K; Ng WF
    Front Immunol; 2021; 12():702505. PubMed ID: 34381453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Th17 cells in primary Sjögren's syndrome: Pathogenicity and plasticity.
    Verstappen GM; Corneth OBJ; Bootsma H; Kroese FGM
    J Autoimmun; 2018 Feb; 87():16-25. PubMed ID: 29191572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
    Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunological alterations in newly diagnosed primary Sjögren's syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines.
    Szodoray P; Gal I; Barath S; Aleksza M; Horvath IF; Gergely P; Szegedi G; Nakken B; Zeher M
    Scand J Rheumatol; 2008; 37(3):205-12. PubMed ID: 18465456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome measures for primary Sjögren's syndrome: a comprehensive review.
    Seror R; Theander E; Bootsma H; Bowman SJ; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Mariette X; Vitali C
    J Autoimmun; 2014 Jun; 51():51-6. PubMed ID: 24411404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-dose immunosuppression and autologous peripheral blood stem cell transplantation for immunological reconstitution in two patients with primary Sjögren's syndrome].
    Zhang ZY; Li RB; Jiang Y; Leng XM; Mei YF; Zhao YP; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):926-9. PubMed ID: 18261277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study.
    Seror R; Nocturne G; Lazure T; Hendel-Chavez H; Desmoulins F; Belkhir R; Ravaud P; Benbijja M; Poirier-Colame V; Taoufik Y; Mariette X
    Arthritis Res Ther; 2015 Sep; 17(1):241. PubMed ID: 26336930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.
    Björk A; Thorlacius GE; Mofors J; Richardsdotter Andersson E; Ivanchenko M; Tingström J; James T; Brokstad KA; Cox RJ; Jonsson R; Kvarnström M; Wahren-Herlenius M
    Rheumatology (Oxford); 2020 Jul; 59(7):1651-1661. PubMed ID: 31665501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.
    Karageorgas T; Fragioudaki S; Nezos A; Karaiskos D; Moutsopoulos HM; Mavragani CP
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):123-31. PubMed ID: 26315379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren's syndrome.
    Hartkamp A; Geenen R; Kruize AA; Bossema ER; Godaert GL; Bootsma H; Bijlsma JW; Derksen RH
    Clin Exp Rheumatol; 2011; 29(2):318-21. PubMed ID: 21504661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
    Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.
    Gudbjörnsson B; Hällgren R; Nettelbladt O; Gustafsson R; Mattsson A; af Geijerstam E; Tötterman TH
    Ann Rheum Dis; 1994 Sep; 53(9):574-9. PubMed ID: 7979595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.